Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Clinical Medicine (London, England)|September 26, 2015
Drug treatment of pruritus in liver diseasesVinod S Hegade, Stuart F W Kendrick, David E J JonesHepatology (Baltimore, Md.)|June 26, 2010
Theophylline improves steroid sensitivity in acute alcoholic hepatitisStuart F W Kendrick, Elsbeth Henderson, Jeremy Palmer, et al.The American Journal of Tropical Medicine and Hygiene|July 9, 2004
Carboxyhemoglobin levels in Kenyan children with Plasmodium falciparum malariaAubrey J Cunnington, Stuart F W Kendrick, Betty Wamola, et al.Trends in Molecular Medicine|January 29, 2008
Interplay between oxidative stress and immunity in the progression of alcohol-mediated liver injuryMatteo Vidali, Stephen F Stewart, Emanuele AlbanoHepatology (Baltimore, Md.)|March 17, 2010
Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitisStuart F W Kendrick, Graeme O'Boyle, Jelena Mann, et al.Gut|August 31, 2010
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver diseaseStuart McPherson, Stephen F Stewart, Elsbeth Henderson, et al.Hepatology (Baltimore, Md.)|January 31, 2004
Oxidative stress as a trigger for cellular immune responses in patients with alcoholic liver diseaseStephen F Stewart, Matteo Vidali, Christopher P Day, et al.BMC Gastroenterology|July 20, 2016
BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trialVinod S Hegade, Stuart F W Kendrick, Robert L Dobbins, et al.Liver International : Official Journal of the International Association for the Study of the Liver|July 10, 2013
Clinical but not histological factors predict long-term prognosis in patients with histologically advanced non-decompensated alcoholic liver diseaseSteven Masson, Ingrid Emmerson, Elsbeth Henderson, et al.Lancet (London, England)|February 12, 2017
Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a studyVinod S Hegade, Stuart F W Kendrick, Robert L Dobbins, et al.Pageof 2